{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:46:48Z","timestamp":1790164008226,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T00:00:00Z","timestamp":1326844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-23","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T19:15:25Z","timestamp":1326914125000},"source":"Crossref","is-referenced-by-count":50,"title":["Obesity, body composition, and prostate cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Jay H","family":"Fowke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saundra S","family":"Motley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul S","family":"Concepcion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Barocas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,18]]},"reference":[{"key":"3034_CR1","volume-title":"Cancer Facts & Figures 2011","author":"American Cancer Society","year":"2011","unstructured":"American Cancer Society: Cancer Facts & Figures 2011. 2011"},{"key":"3034_CR2","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schroder","year":"2009","unstructured":"Schroder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009, 360: 1320-1328. 10.1056\/NEJMoa0810084.","journal-title":"N Engl J Med"},{"issue":"2","key":"3034_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1056\/NEJMp1106783","volume":"365","author":"MR Theoret","year":"2011","unstructured":"Theoret MR, Ning YM, Zhang JJ, Justice R, Keegan P, Pazdur R: The Risks and Benefits of 5alpha-Reductase Inhibitors for Prostate-Cancer Prevention. N Engl J Med. 2011, 365 (2): 97-99. 10.1056\/NEJMp1106783.","journal-title":"N Engl J Med"},{"key":"3034_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2217\/14796694.3.5.557","volume":"3","author":"AR Kristal","year":"2007","unstructured":"Kristal AR, Gong Z: Obesity and prostate cancer mortality. Future Oncol. 2007, 3: 557-567. 10.2217\/14796694.3.5.557.","journal-title":"Future Oncol"},{"key":"3034_CR5","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/aje\/kwm013","volume":"165","author":"AJ Littman","year":"2007","unstructured":"Littman AJ, White E, Kristal AR: Anthropometrics and prostate cancer risk. Am J Epidemiol. 2007, 165: 1271-1279. 10.1093\/aje\/kwm013.","journal-title":"Am J Epidemiol"},{"key":"3034_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/sj.pcan.4501022","volume":"11","author":"JH Fowke","year":"2008","unstructured":"Fowke JH, Matthews CM, Buchowski MS, Signorello LB, Chang SS, Cookson MS, et al: Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men. Prostate Cancer Prostatic Dis. 2008, 11: 264-269. 10.1038\/sj.pcan.4501022.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3034_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","volume":"3","author":"A DeCensi","year":"2010","unstructured":"DeCensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, et al: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res. 2010, 3: 1451-1461. 10.1158\/1940-6207.CAPR-10-0157.","journal-title":"Cancer Prev Res"},{"key":"3034_CR8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ijo.2010.5","volume":"34","author":"DO Okorodudu","year":"2010","unstructured":"Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al: Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010, 34: 791-799. 10.1038\/ijo.2010.5.","journal-title":"Int J Obes (Lond)"},{"key":"3034_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ijo.2008.11","volume":"32","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, et al: Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008, 32: 959-966. 10.1038\/ijo.2008.11.","journal-title":"Int J Obes (Lond)"},{"key":"3034_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1258\/jrsm.99.5.250","volume":"99","author":"M Ezzati","year":"2006","unstructured":"Ezzati M, Martin H, Skjold S, Vander HS, Murray CJ: Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med. 2006, 99: 250-257. 10.1258\/jrsm.99.5.250.","journal-title":"J R Soc Med"},{"key":"3034_CR11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10552-006-0049-z","volume":"17","author":"R MacInnis","year":"2006","unstructured":"MacInnis R, English D: Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control. 2006, 17: 989-1003. 10.1007\/s10552-006-0049-z.","journal-title":"Cancer Causes Control"},{"key":"3034_CR12","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/sj.bjc.6605077","volume":"100","author":"P Wallstrom","year":"2009","unstructured":"Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E: A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer. 2009, 100: 1799-1805. 10.1038\/sj.bjc.6605077.","journal-title":"Br J Cancer"},{"key":"3034_CR13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/ajcn\/81.6.1313","volume":"81","author":"SG Wannamethee","year":"2005","unstructured":"Wannamethee SG, Shaper AG, Morris RW, Whincup PH: Measures of adiposity in the identification of metabolic abnormalities in elderly men. Am J Clin Nutr. 2005, 81: 1313-1321.","journal-title":"Am J Clin Nutr"},{"key":"3034_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00075197-200207000-00012","volume":"5","author":"UG Kyle","year":"2002","unstructured":"Kyle UG, Genton L, Pichard C: Body composition: what's new?. Curr Opin Clin Nutr Metab Care. 2002, 5: 427-433. 10.1097\/00075197-200207000-00012.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3034_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jacc.2010.09.040","volume":"57","author":"B Niemann","year":"2011","unstructured":"Niemann B, Chen Y, Teschner M, Li L, Silber RE, Rohrbach S: Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol. 2011, 57: 577-585. 10.1016\/j.jacc.2010.09.040.","journal-title":"J Am Coll Cardiol"},{"key":"3034_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ajcn\/81.1.74","volume":"81","author":"G Sun","year":"2005","unstructured":"Sun G, French CR, Martin GR, Younghusband B, Green RC, Xie YG, et al: Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr. 2005, 81: 74-78.","journal-title":"Am J Clin Nutr"},{"key":"3034_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1463-1326.2008.00851.x","volume":"10","author":"Z Boneva-Asiova","year":"2008","unstructured":"Boneva-Asiova Z, Boyanov MA: Body composition analysis by leg-to-leg bioelectrical impedance and dual-energy X\u0393\u00c7\u00f4ray absorptiometry in non-obese and obese individuals. Diabetes Obes Metab. 2008, 10: 1012-1018. 10.1111\/j.1463-1326.2008.00851.x.","journal-title":"Diabetes Obes Metab"},{"key":"3034_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0899-9007(03)00172-2","volume":"19","author":"DK Dey","year":"2003","unstructured":"Dey DK, Bosaeus I: Comparison of bioelectrical impedance prediction equations for fat-free mass in a population-based sample of 75 y olds: the NORA study. Nutrition. 2003, 19: 858-864. 10.1016\/S0899-9007(03)00172-2.","journal-title":"Nutrition"},{"key":"3034_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cardfail.2010.06.416","volume":"16","author":"A Oreopoulos","year":"2010","unstructured":"Oreopoulos A, Kalantar-Zadeh K, McAlister FA, Ezekowitz JA, Fonarow GC, Johnson JA, et al: Comparison of direct body composition assessment methods in patients with chronic heart failure. J Card Fail. 2010, 16: 867-872. 10.1016\/j.cardfail.2010.06.416.","journal-title":"J Card Fail"},{"key":"3034_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ncb0203-87","volume":"5","author":"DJ Glass","year":"2003","unstructured":"Glass DJ: Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol. 2003, 5: 87-90. 10.1038\/ncb0203-87.","journal-title":"Nat Cell Biol"},{"key":"3034_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1677\/JOE-09-0431","volume":"205","author":"S Perrini","year":"2010","unstructured":"Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F: The GH\/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol. 2010, 205: 201-210. 10.1677\/JOE-09-0431.","journal-title":"J Endocrinol"},{"key":"3034_CR22","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/jnci\/94.14.1099","volume":"94","author":"JM Chan","year":"2002","unstructured":"Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, et al: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst. 2002, 94: 1099-1106. 10.1093\/jnci\/94.14.1099.","journal-title":"J Natl Cancer Inst"},{"key":"3034_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00008469-200308000-00011","volume":"12","author":"R Kaaks","year":"2003","unstructured":"Kaaks R, Lukanova A, Rinaldi S, Biessy C, Soderberg S, Olsson T, et al: Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls. Eur J Cancer Prev. 2003, 12: 309-315. 10.1097\/00008469-200308000-00011.","journal-title":"Eur J Cancer Prev"},{"key":"3034_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jnci\/djj013","volume":"98","author":"I Cheng","year":"2006","unstructured":"Cheng I, Stram DO, Penney KL, Pike M, Le Marchand L, Kolonel LN, et al: Common genetic variation in IGF1 and prostate cancer risk in the multiethnic cohort. JNCI Cancer Spect. 2006, 98: 123-134.","journal-title":"JNCI Cancer Spect"},{"key":"3034_CR25","first-page":"4407","volume":"63","author":"L Wang","year":"2003","unstructured":"Wang L, Habuchi T, Tsuchiya N, Mitsumori K, Ohyama C, Sato K, et al: Insulin-like growth factor-binding protein-3 gene-202 A\/C polymorphism is correlated with advanced disease status in prostate cancer. Cancer Res. 2003, 63: 4407-4411.","journal-title":"Cancer Res"},{"key":"3034_CR26","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1158\/1078-0432.CCR-09-1955","volume":"16","author":"G Zadra","year":"2010","unstructured":"Zadra G, Priolo C, Patnaik A, Loda M: New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK. Clin Cancer Res. 2010, 16: 3322-3328. 10.1158\/1078-0432.CCR-09-1955.","journal-title":"Clin Cancer Res"},{"key":"3034_CR27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al: Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001, 3: 1014-1019. 10.1038\/ncb1101-1014.","journal-title":"Nat Cell Biol"},{"key":"3034_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa030660","volume":"349","author":"IM Thompson","year":"2003","unstructured":"Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al: The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003, 349: 213-222. 10.1056\/NEJMp038121.","journal-title":"N Engl J Med"},{"key":"3034_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s11934-009-0042-7","volume":"10","author":"MM Miner","year":"2009","unstructured":"Miner MM: Primary care physician versus urologist: how does their medical management of LUTS associated with BPH differ?. Curr Urol Rep. 2009, 10: 254-260. 10.1007\/s11934-009-0042-7.","journal-title":"Curr Urol Rep"},{"key":"3034_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1521-690X(03)00018-6","volume":"17","author":"MA Yialamas","year":"2003","unstructured":"Yialamas MA, Hayes FJ: Androgens and the ageing male and female. Best Pract Res Clin Endocrinol Metab. 2003, 17: 223-236. 10.1016\/S1521-690X(03)00018-6.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3034_CR31","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1210\/jc.2008-2338","volume":"94","author":"FR Sattler","year":"2009","unstructured":"Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, et al: Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab. 2009, 94: 1991-2001. 10.1210\/jc.2008-2338.","journal-title":"J Clin Endocrinol Metab"},{"key":"3034_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sj.pcan.4500924","volume":"10","author":"JH Fowke","year":"2006","unstructured":"Fowke JH, Motley SS, Cookson MS, Concepcion R, Chang SS, Wills ML, et al: The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis. 2006, 10: 137-142.","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T17:07:26Z","timestamp":1561223246000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3034"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-23","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,18]]},"article-number":"23"}}